ClinicalTrials.Veeva

Menu

Blood Nitrate/Nitrite Concentrations Following Acute Ingestion of Resync in Men and Women

University of Memphis logo

University of Memphis

Status

Completed

Conditions

Healthy

Treatments

Dietary Supplement: Resync + Collagen
Dietary Supplement: Resync
Other: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT04125940
PRO-FY2020-67

Details and patient eligibility

About

This study evaluates acute ingestion of the dietary supplement Resync on blood nitrate/nitrite concentrations in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.

Full description

The product known as Resync contains a blend of nitrate-rich foods including beetroot, red spinach, turmeric, ginger root, and aronia berry extracts. Resync is sold commercially and marketed as an ergogenic aid and/or exercise recovery aid. Manufacturers of Resync recommend users take this product 60-90 minutes before an athletic event or 30-90 minutes after exercise. Resync bases these claims on prior studies investigating the individual ingredients' abilities to increase blood nitrate/nitrite levels; however, there are no clinical trials on the finished product itself.

The purpose of this pilot study is to determine the impact of acute, single ingestion of Resync products on blood nitrate/nitrite concentration in a sample of men and women. This will be a crossover trial in which participants take all 4 conditions: 1) 7.5g Resync, 2) 15g Resync, 3) 20g Resync+collagen, 4) placebo.

Enrollment

20 patients

Sex

All

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • BMI 18 - 29.9 kg/m2
  • Non-smoker
  • Non-vegan
  • Not using nitrate-based dietary supplements

Exclusion criteria

  • Diagnosed history of diabetes
  • Diagnosed history of cardiovascular disease
  • Diagnosed history of neurological disease
  • Pregnant females

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

20 participants in 4 patient groups, including a placebo group

Placebo-controlled Arm
Placebo Comparator group
Description:
Placebo - 12oz water with food coloring
Treatment:
Other: Placebo
1 serving Resync Arm
Active Comparator group
Description:
12oz water + 7.5g Resync
Treatment:
Dietary Supplement: Resync
2 servings Resync Arm
Active Comparator group
Description:
12oz water + 15g Resync
Treatment:
Dietary Supplement: Resync
1 servings Resync+Collagen Arm
Active Comparator group
Description:
12oz water + 17g collagen + 2g Resync + 1g Carbohydrates
Treatment:
Dietary Supplement: Resync + Collagen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems